It was observed earlier that administration of GM-CSF in sepsis patients reversed the monocytic deactivation by increasing HLADR and TLR4-induced cytokine production, as well as decreased the time of mechanical ventilation and length of hospital (34). The gene discussed is CSF2; the disease is Sepsis.